Douglas Hospital was founded in 1881 by Alfred Perry and a group of Protestant clergy and Montréal citizens.

Cognitive remediation is a computer-assisted therapy that promotes the stimulation of cognitive skills necessary for everyday life. Many studies have shown this therapy to have a measurable impact on cognitive deficits related to dementia, making it an invaluable intervention tool in the treatment of Alzheimer's disease.

Her current research interests lie in the areas of molecular genetic and personality factors that influence eating disorder symptoms and treatment outcomes.

Andrée Daigneault  MD, is interested in the rehabilitation of young adults aged 18 to 30 who suffer from bipolar disorders

Pierre Étienne is a psychiatrist in the geriatric psychiatry program of the Douglas Institute. He is interested in the early development of medication and in Alzheimer's Disease.

Eduardo Chachamovich’s work focuses mainly on social and clinical determinants of mental health in Aboriginal populations.

Fabrice Jollant's research focuses on the cognitive and cerebral bases of vulnerability to suicide.

Ashok Malla is an international leader in the development of programs for, and research in, early intervention in psychosis.

Marc Laporta, MD, develops international collaborative ventures  in the area of emergencies and disasters for the Americas.

As a clinician, Johanne Renaud holds the title of medical chief for the youth section of the Douglas Institute’s Depressive Disorders Program.